Baumhof et al.
50.8, 40.0; HR-MS (EI) C16H16IN3O5 calcd 457.0135, found
457.0132.
with brine (30 mL). The organic phase was dried over Na2SO4,
the volume was reduced in vacuo to 0.5 mL, and the solution was
added dropwise to pentanes (20 mL). The supernatant was aspired,
and the oily residue was dried in vacuo to give the title compound
(mixture of diastereomers) as a colorless foam (49 mg, 0.06 mmol,
74%). 31P NMR (CD3CN-d3, 300 MHz) δ 150.2, 150.5.
5′-O-Benzoyl-2′,3′-dideoxy-5-iodo-3′-(tritylamino)uridine (5).
To a solution of 4 (0.2 g, 0.43 mmol) in dry CH2Cl2 (5 mL) was
added NEt3 (0.13 mL, 0.56 mmol, 1.3 equiv), followed by the
dropwise addition of trityl chloride (0.16 g, 0.56 mmol, 1.3 equiv)
in CH2Cl2 (2 mL). After 3 h, the reaction was quenched with
saturated aqueous NaHCO3 (100 mL) and extracted three times with
100 mL of CH2Cl2. The combined organic phases were dried over
Na2SO4 and concentrated in vacuo. Purification on silica (20:1
CH2Cl2/MeOH, RF ) 0.56) afforded the title compound, which
5′-O-Benzoyl-2′,3′-dideoxy-5-iodo-3′-(trifluoroacetylamido)-
uridine (9). Amine 4 (0.92 g, 2.01 mmol) was dissolved in 25 mL
of CH2Cl2, and trifluoracetic acid anhydride (640 mg, 3.02 mmol,
1.5 equiv) and pyridine (377 µL, 370 mg, 4.05 mmol, 2 equiv)
were added under stirring. After 30 min, the solution was partioned
between 100 mL of saturated aqueous NaHCO3 and 100 mL of
CH2Cl2. Concentration of the organic phase in vacuo and purifica-
tion on silica [1:2 (v/v) hexanes/ethyl acetate, RF ) 0.75] gave a
1
crystallized upon standing (0.22 g, 0.39 mmol, 73%). H NMR
(CDCl3, 500 MHz) δ 2.41 (m, 1H), 2.61 (m, 1H), 4.27 (t, J ) 3.6
Hz, 1H), 4.36 (m, 1H), 4.63 (d, J ) 3.7 Hz, 2H), 6.12 (t, J ) 6.4
Hz, 1H), 7.37 (m, 10H), 7.45 (m, 2H), 7.61 (m, 7H), 7.88 (s, 1H),
8.05 (d, J ) 8.3 Hz, 3H), 9.2 (s, 1H); 13C NMR (CDCl3, 125 MHz)
δ 166.1, 160.1, 149.8, 144.0, 133.7, 129.8, 129.0, 128.9, 86.1, 82.5,
68.9, 63.7, 60.4, 38.3; FAB-MS (3-NBA) m/z 699.2.
1
colorless solid. (0.76 g, 1.37 mmol, 68%). H NMR (CDCl3, 500
MHz) δ 2.31 (m, 1H), 2.71 (d, J ) 11.1 Hz, 1H), 4.57-4.75 (m,
3H), 6.26 (s, 1H), 7.49 (t, J ) 7.5 Hz, 2H), 7.62 (t, J ) 7.0 Hz,
1H), 7.87 (s, 1H), 8.07 (d, J ) 7.8 Hz, 2H), 8.2 (br s, 1H), 10.3 (br
s, 1H); 13C NMR (CDCl3, 125 MHz) δ 166.3, 144.9, 144.6, 133.4,
133.1, 129.3, 128.4, 128.4, 126.4, 90.6, 86.0, 84.9, 81.8, 63.6, 50.0,
36.5; HR-MS (EI) m/z for C18H15N3F3IO6 calcd 552.9958, found
552.9957.
2′,3′-Dideoxy-5-iodo-3′-(trifluoroacetylamido)uridine (10). To
a solution of 9 (100 mg, 0.18 mmol) in MeOH (4 mL) was added
aqueous NaOH (0.72 mL, 1 M, 4 equiv). After TLC showed that
the reaction was complete (typically 0.5-1 h), water (10 mL) was
added, and the resulting mixture was extracted three times with
100 mL of ethyl acetate. The combined organic phases were dried
over Na2SO4 and concentrated in vacuo. Purification on silica [1:2
(v/v) hexanes/ethyl acetate, RF ) 0.5] gave the title compound as
a colorless solid (0.076 g, 0.17 mmol, 94%). 1H NMR (MeOH-d4,
500 MHz) δ 2.32 (t, J ) 6.6 Hz, 2H), 3.59 (dd, J ) 12.1, 3.3 Hz,
1H), 3.74 (dd, J ) 12.1 Hz, 2.5 Hz, 1H), 3.88 (m, 1H), 4.50 (m,
1H), 6.08 (t, J ) 6.6 Hz), 8.45 (s, 1H); 13C NMR (MeOH-d4, 125
MHz) δ 161.3, 157.6, 157.3, 150.4, 145.6, 114.4, 85.3, 84.7, 60.5,
49.1, 37.1; HR-MS (EI) m/z for C11H11N3F3IO5 calcd 448.9695,
found 448.9694.
2′,3′-Dideoxy-5-iodo-3′-(trifluoroacetylamido)uridin-5′-O-yl-
â-cyanoethyl-N,N-diisopropyl-phosphoramidite (11). To a stirred
solution of 10 (125 mg, 0.27 mmol) and diisopropylethylamine (141
µL, 0.81 mmol, 3 equiv) in anhydrous CH3CN (2.0 mL) was added
2-cyanoethyl-N,N-diisopropyl chlorophosphoramidite (70 µL, 0.81
mmol, 1.1 equiv). The solution was stirred for 30 min. After TLC
indicated complete conversion, CH2Cl2 (20 mL) was added, and
the solution was washed with saturated NaHCO3 solution (2 × 30
mL) and with brine (30 mL). The organic phase was dried over
Na2SO4, and the solvent was evaporated to an approximate volume
of 0.5 mL. This solution was added dropwise to pentanes (20 mL).
The supernatant was aspired, and the oily residue was dried in
vacuo, yielding the title compound (mixture of diastereomers) as a
colorless foam (141 mg, 0.22 mmol, 80%). 31P NMR (CD3CN-d3,
300 MHz) δ 149.9, 150.3.
DNA Synthesis. Oligodeoxynucleotides were prepared on 1
µmol scale on a model 8909 Expedite synthesizer, software 2.01
(Perseptive Biosystems) using the standard protocol, except that
5′-phosphoramidites (reverse phosphoramidites) were used. Cou-
pling of 11 to the unmodified portion of the strand used a 0.4 M
solution in CH3CN that had been dried over 4-Å molecular sieves.
All oligodeoxynucleotides were deprotected and cleaved from the
solid support using concentrated aqueous ammonia for 5 h at 65
°C. After being cooled to room temperature., the supernatant was
collected, and the residue was washed with deionized water. Excess
ammonia was removed from the combined aqueous solutions with
a gentle stream of compressed air, followed by lyophilization to
dryness. The residue was taken up with deionized water, filtered,
and subjected to HPLC purification.
5-[3-N-(Allyloxycarbonyl)aminopropyn-1-yl]-5′-O-benzoyl-
2′,3′-dideoxy-3′-(tritylamino)uridine (6). A solution of 5 (150 mg,
0.21 mmol) in DMF (2 mL) was degassed under reduced pressure
and placed under argon. Then, Pd(PPh3)4 (25.0 mg, 21 µmol, 0.1
equiv), CuI (8.0 mg, 42 µmol, 0.2 equiv), N-alloc-protected
propargylamine (39.0 mg, 0.28 mmol, 1.3 equiv), and NEt3 (0.09
mL, 0.63 mmol, 3 equiv) were added, and the solution was stirred
for 4 h at room temperature. After addition of an aqueous solution
of EDTA (0.14 M), the mixture was extracted with ethyl acetate
(3 × 100 mL), and the combined organic phases were dried over
Na2SO4, concentrated in vacuo, and subjected to chromatography
(silica, 2:1 hexanes/ethyl acetate, RF ) 0.5), yielding a pale yellow
oil (79 mg, 0.11 mmol, 53%). 1H NMR (CDCl3, 500 MHz) δ 1.27
(m, 1H), 1.75 (m, 1H), 1.90 (m, 2H), 3.40 (m, 1H), 3.90 (dq, J )
17.6, 5.2 Hz, 2H), 4.03 (m, 1H), 4.39 (dd, J ) 12.5, 4.0 Hz, 1H),
4.57 (m, 3H), 4.87 (br s, 1H), 5.29 (d, J ) 1.5 Hz, 1H), 5.32 (d, J
) 1.5 Hz, 1H), 5.91 (m, 1H), 5.99 (t, J ) 5.3 Hz, 1H), 7.13-7.29
(m, 10 H), 7.45 (t, J ) 8.2 Hz, 2H), 7.60-7.69 (m, 7H), 7.89 (dd,
J ) 8.0, 0.9 Hz, 2H), 8.84 (s br, 1H); 13C NMR (CDCl3, 125 MHz)
δ 166.2, 161.3, 155.8, 148.8, 145.8, 145.7, 142.1, 133.3, 132.6,
129.6, 129.3, 128.6, 128.4, 128.2, 126.9, 117.8, 99.3, 89.5, 85.7,
84.3, 74.1, 71.2, 65.8, 63.6, 53.6, 40.6, 31.5; FAB-MS (3-NBA)
m/z 711.3.
5-[3-N-(Allyloxycarbonyl)aminopropyn-1-yl]-2′,3′-dideoxy-3′-
(tritylamino) uridine (7). To a solution of 6 (73.0 mg, 0.1 mmol)
in MeOH (3 mL) was added aqueous NaOH (0.3 mL, 1 M, 3 equiv)
at room temperature. After 3 h, water (10 mL) was added, and the
resulting mixture was extracted with ethyl acetate (3 × 100 mL).
The combined organic phases were dried over Na2SO4 and
concentrated in vacuo. Chromatographic purification on silica (1:2
hexanes/ethyl acetate, RF ) 0.6) gave a colorless solid (0.03 g,
1
0.06 mmol, 58%). H NMR (CDCl3, 500 MHz) δ 1.32 (m, 1H),
1.45 (m, 1H), 1.94 (s, 2H), 2.96 (s, 1H), 3.40 (m, 1H), 3.62 (m,
1H), 3.71 (m, 1H), 3.69 (m, 1H), 3.88 (m, 1H), 3.92 (m, 1H), 4.55
(d, J ) 5.3 Hz, 1H), 5.20 (d, J ) 1.3 Hz, 2H), 5.53 (d, J ) 4.9 Hz,
1H), 5.94 (m, 1H), 5.99 (t, J ) 6.3 Hz, 1H), 7.16 (t, J ) 7.1 Hz,
3H), 7.20-7.30 (m, 6H), 7.53 (d, J ) 7.4 Hz, 6H), 7.91 (s, 1H),
9.12 (s, 1H); 13C NMR (CDCl3, 125 MHz) δ 171.2, 161.7, 156.1,
149.1, 146.1, 146.0, 143.8, 132.6, 132.1, 128.6, 128.1, 126.8, 117.9,
98.9, 89.6, 87.3, 85.5, 77.7, 77.2, 74.3, 71.2, 65.9, 61.7, 53.1, 40.4,
31.6; MALDI-TOF MS (linear, positive mode) m/z C35H34N4O6
calcd 606.2 [M + H], 629.1 [M + Na], found 606.8, 629.8.
5-[3-N-(Allyloxycarbonyl)aminopropyn-1-yl]-2′,3′-dideoxy-3′-
(tritylamino) uridin-5′-O-yl-â-cyanoethyl-N,N-diisopropyl phos-
phoramidite (8). To a stirred solution of 7 (50.0 mg, 0.08 mmol)
and diisopropylethylamine (42 µl, 0.24 mmol, 3 equiv) in anhydrous
CH3CN (2.0 mL) was added 2-cyanoethyl-N,N-diisopropyl chloro-
phosphoramidite (30 µL, 0.12 mmol, 1.5 equiv). The solution was
stirred for 30 min at room temperature. After TLC indicated
complete conversion, CH2Cl2 (20 mL) was added, and the solution
was washed with saturated aqueous NaHCO3 (2 × 30 mL) and
Compound 22. The last extension cycle of the DNA synthesis
used a 3′-MMT-protected phosphoramidite of 3′-amino-3′-deoxy-
thymidine (ChemGenes). The MMT group was removed using the
1066 J. Org. Chem., Vol. 71, No. 3, 2006